Prophylactic Cranial Irradiation for Patients with Small Cell Lung Cancer in Germany: Pattern of Care Survey

Background/Aim: The general pattern of care regarding the application of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC) patients in Germany has not been previously evaluated. This survey was conducted to assess patterns of care. Patients and Methods: Radiation oncology institutions in Germany were surveyed via an anonymous online questionnaire sent by e-mail to member institutions of the German Society for Radiation Oncology. Results: A total of 95 responses were received (29% response rate). Eighty-eight percent of all responders recommended a PCI total dose of 30Gy delivered in 15 daily fractions. Overall, 11 and 38% of the respondents applied PCI simultaneously with chemo- and radiotherapy, respectively. A quarter of respondents offered hippocampal-avoidance PCI and followed their patients with serial brain imaging. Conclusion: PCI with a total dose of 30 Gy in 15 daily fractions, without neuropsychological testing and hippocampus-avoidance, delivered after completion of primary multimodal treatment remains standard in Germany.

[1]  Matthew P. Goetz,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[2]  Charles R. Thomas,et al.  Prophylactic Cranial Irradiation for Limited‐Stage Small‐Cell Lung Cancer: Survey of US Radiation Oncologists on Current Practice Patterns , 2018, Clinical lung cancer.

[3]  R. Bremnes,et al.  Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement. , 2018, Anticancer research.

[4]  G. Rosner,et al.  Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer. , 2017, International journal of radiation oncology, biology, physics.

[5]  T. Yamanaka,et al.  Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial. , 2017, The Lancet. Oncology.

[6]  D. Rades,et al.  Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer. , 2017, Anticancer research.

[7]  D. Rades,et al.  Karnofsky Performance Score, Radiation Dose and Nodal Status Predict Survival of Elderly Patients Irradiated for Limited-disease Small-cell Lung Cancer. , 2016, Anticancer Research.

[8]  Charles R. Thomas,et al.  Current Patterns of Care for Patients with Extensive‐Stage SCLC: Survey of U.S. Radiation Oncologists on Their Recommendations Regarding Prophylactic Cranial Irradiation , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  Z. Gabos,et al.  Management of small-cell lung cancer with radiotherapy-a pan-Canadian survey of radiation oncologists. , 2016, Current oncology.

[10]  Wolfgang A Tome,et al.  Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P. Brown,et al.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. , 2013, Neuro-oncology.

[12]  D. de Ruysscher,et al.  Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[13]  L. Collette,et al.  Prophylactic cranial irradiation in extensive small-cell lung cancer. , 2007, The New England journal of medicine.

[14]  Edward L Spitznagel,et al.  Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  J P Pignon,et al.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. , 1999, The New England journal of medicine.

[16]  H. Choy,et al.  National survey on prophylactic cranial irradiation: differences in practice patterns between medical and radiation oncologists. , 1999, International journal of radiation oncology, biology, physics.

[17]  P Chomy,et al.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. , 1995, Journal of the National Cancer Institute.

[18]  J. Cox,et al.  Risk of brain metastasis from small cell carcinoma of the lung related to length of survival and prophylactic irradiation. , 1981, Cancer treatment reports.

[19]  J. Minna,et al.  CNS metastases in small cell bronchogenic carcinoma. Increasing frequency and changing pattern with lengthening survival , 1979, Cancer.